Achieve Life Sciences, Inc. Deferred Income Tax Expense (Benefit)
Achieve Life Sciences, Inc. (ACHV) reported Deferred Income Tax Expense (Benefit) of -$3.05 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2018-03-01
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for the quarter ending 2017-12-31 was $0.00.
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for the quarter ending 2017-09-30 was -$2.93M.
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for the quarter ending 2017-06-30 was $0.00.
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for the quarter ending 2017-03-31 was -$124.00K.
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for fiscal 2017 was -$3.05M.
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for fiscal 2016 was -$504.00K.
- Achieve Life Sciences, Inc. deferred income tax expense (benefit) for fiscal 2015 was -$407.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 8 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$2.93M derived: sum of 2 quarters · filed 2018-03-01 | -$2.93M derived: sum of 3 quarters · filed 2018-03-01 | -$3.05M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | -$2.93M 10-K · filed 2018-03-01 | -$2.93M 10-Q · filed 2017-11-09 | -$2.93M derived: sum of 2 quarters · filed 2018-03-01 | -$3.05M 10-Q · filed 2017-11-09 | -$3.18M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2017-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-03-01 | -$124.00K derived: sum of 2 quarters · filed 2018-03-01 | -$251.00K derived: sum of 3 quarters · filed 2018-03-01 | -$388.00K derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2017-03-31 | -$124.00K 10-K · filed 2018-03-01 | -$251.00K derived: sum of 2 quarters · filed 2018-03-01 | -$388.00K derived: sum of 3 quarters · filed 2018-03-01 | -$510.00K derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-12-31 | -$127.00K 10-K · filed 2018-03-01 | -$264.00K derived: sum of 2 quarters · filed 2018-03-01 | -$386.00K derived: sum of 3 quarters · filed 2018-03-01 | -$504.00K 10-K · filed 2018-03-01 | ||
| 2016-09-30 | -$137.00K 10-K · filed 2018-03-01 | -$259.00K derived: sum of 2 quarters · filed 2018-03-01 | -$377.00K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$122.00K 10-K · filed 2018-03-01 | -$240.00K derived: sum of 2 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | -$118.00K 10-K · filed 2018-03-01 | |||||
| 2015-12-31 | -$407.00K 10-K · filed 2018-03-01 | -$407.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |